Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. (Q27852408)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. |
scientific article |
Statements
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations (English)
Nobuyuki Yamamoto
Kenneth O'Byrne
Vera Hirsh
Sarayut Lucien Geater
Chun-Ming Tsai
Jaafar Bennouna
Terufumi Kato
Ki Hyeong Lee
Riyaz Shah
Dan Massey
Victoria Zazulina
Mehdi Shahidi
Martin Schuler
Identifiers
2 references
2 references